Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
aap Implantate AGXTER:AAQ1 43 10-Year RORE % is -14.50 as of Jun. 2026. GuruFocus rates XTER:AAQ1 with a GF Score™ of 43/100 and a GF Value™ of €0.99 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 431 Medical Devices & Instruments companies, aap Implantate AG ranks worse than 76.1% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
aap Implantate AG's 10-Year RORE % for the quarter that ended in Jun. 2026 was -14.50%.
The industry rank for aap Implantate AG's 10-Year RORE % or its related term are showing as below:
XTER:AAQ1's 10-Year RORE % is ranked worse than 76.1% of 431
companies
in the Medical Devices & Instruments industry
Industry Median: 0.95
vs XTER:AAQ1: -14.50
aap Implantate AG (XTER:AAQ1) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
aap Implantate AG 10-Year RORE % Related Terms
aap Implantate AG 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AAQ1 vs ABT, SYK, MDT: 10-Year RORE % Comparison
For the Medical Devices subindustry, aap Implantate AG's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG 10-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 10-year before.
aap Implantate AG (XTER:AAQ1) has a 10-Year RORE % of -14.50 as of Jun. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #328 out of 431 companies in the Medical Devices & Instruments industry, placing it in the top 76.1%.
Is aap Implantate AG's 10-Year RORE % too high?
aap Implantate AG's current 10-Year RORE % is -14.50. Based on the distribution chart, aap Implantate AG ranks #328 out of 431 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, aap Implantate AG has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's 10-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #328 out of 431 companies for 10-Year RORE %. This places aap Implantate AG in the lower half of its industry. The industry median 10-Year RORE % is 0.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Devices & Instruments company?
The median 10-Year RORE % among Medical Devices & Instruments companies is 0.95, based on 431 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median 10-Year RORE % is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current 10-Year RORE % is -14.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
Based on GuruFocus' analysis, aap Implantate AG (XTER:AAQ1) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.99, compared to a current price of €1.47 — trading 48.5% above its estimated fair value. The current 10-Year RORE % is -14.50. aap Implantate AG's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For aap Implantate AG (XTER:AAQ1), the current 10-Year RORE % is -14.50 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (XTER:AAQ1) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €1.47 is trading 48.5% above its estimated GF Value™ of €0.99.
GuruFocus considers aap Implantate AG to be Significantly Overvalued.
Key valuation signals for XTER:AAQ1:
10-Year RORE %: -14.50
GF Value™: €0.99 vs. price of €1.47 (48.5% above fair value)
No single metric tells the full story. See the XTER:AAQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
43GF Score
Get the complete analysis for XTER:AAQ1
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AAQ1 has been successfully added to your 
